India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
What precautions should be taken when going for a morning walk in winter? Exercise or morning walk is very beneficial for health. But it is said that it is harmful to go out for a morning walk in Kathmandu in winter. In winter, colds are common in the morning. The harmful particles in the air are fine carbon monoxide, carbon dioxide, sulfur dioxide and nitrogen oxide and ozone, which make the air harmful or polluted. In winter, the wind is less. Due to which the pollution accumulates in one place. In a city like Kathmandu, the cold-hot air column acts as a blanket during the winter season and keeps pollution at bay. That is why the environment is more polluted in winter. Since Kathmandu is shaped like a bowl and the air pollution is high, the air in the morning is also contaminated. In such a situation, doctors say that there will be serious problems in the heart and lungs when going on a morning visit. With the onset of winter, the air flow decreases and cold-warm air forms a lay...